Flubrotizolam Chemical Properties

Boiling point:

535.7±60.0 °C(Predicted)

Density 

1.76±0.1 g/cm3(Predicted)

solubility 

DMF:5.0(Max Conc. mg/mL);13.0(Max Conc. mM)
DMSO:5.0(Max Conc. mg/mL);13.0(Max Conc. mM)
DMSO:PBS (pH 7.2) (1:1):0.5(Max Conc. mg/mL);1.3(Max Conc. mM)

pka

1.98±0.40(Predicted)

form 

A crystalline solid

InChI

InChI=1S/C15H10BrFN4S/c1-8-19-20-13-7-18-14(9-4-2-3-5-11(9)17)10-6-12(16)22-15(10)21(8)13/h2-6H,7H2,1H3

InChIKey

VOZDBDBHBXLWCG-UHFFFAOYSA-N

SMILES

N12C(C)=NN=C1CN=C(C1=CC=CC=C1F)C1C=C(Br)SC=12

Flubrotizolam Usage And Synthesis

Description

Flubrotizolam is an analytical reference standard categorized as a thienodiazepine. This product is intended for research and forensic applications.

Uses

Flubrotizolam is a thienotriazolodiazepine derivative with potent sedative and anxiolytic effects, which has been sold as a designer drug.

Health effects

Flubrotizolam is a synthetic benzodiazepine derivative that has sedative, anxiolytic, and muscle relaxant properties. It is a potent agonist at the GABA-A receptor, which is the same receptor targeted by other benzodiazepines like Valium and Xanax. Flubrotizolam has not been approved for medical use and is considered a designer drug. It has been reported to be sold on the illicit drug market and can pose significant health risks due to its potency and potential for abuse.